Supernus Pharmaceuticals Inc. (SUPN) Rose 5.16% or 2.85 To Price $58.05 On Wednesday


Supernus Pharmaceuticals Inc. (SUPN) rose 5.16% or 2.85 to $58.05. It is near 1.56 million shares traded, which is 180.41% compare to the average total volume 865118. The market cap of SUPN is $3.01 billion. The year to date change is 41.63%. The 52 week price range is from $33.3 to $59.05. Price of SUPN have changed 2.13% during last week. It have changed 0.36% over last month, 23.77% over last 3 months, 45.26% over last 6 months and 37.14% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for SUPN is 51.64. It is -11.04% below current price. The 200-day Moving Averages for SUPN is 43.85. It is -24.46% below current price. The 52-week High is 59.05. It is 1.72% from the current price. The 52-week Low is 33.3. It is -42.64% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of SUPN is 6.1 on 2018-05-31. Short % to float is 11.19%. There are some statistics of SUPN. It is has market cap $3.01 billion. The share outstanding is 51.80 million. The average volume is 865118. The revenue is 156.23M. The gross profit is 148.12M. The percent of top 15 Institution holding is 85.20%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of SUPN is 24.85%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of SUPN is 12.24%.


Tags:

Share this post